25-Hydroxyvitamin D concentrations are lower in patients with positive PCR for SARS-CoV-2 A D’Avolio, V Avataneo, A Manca, J Cusato, A De Nicolò, R Lucchini, ... Nutrients 12 (5), 1359, 2020 | 556 | 2020 |
Coronavirus disease 2019 and first-trimester spontaneous abortion: a case-control study of 225 pregnant patients S Cosma, AR Carosso, J Cusato, F Borella, M Carosso, M Bovetti, ... American journal of obstetrics and gynecology 224 (4), 391. e1-391. e7, 2021 | 168 | 2021 |
LC-MS application for therapeutic drug monitoring in alternative matrices V Avataneo, A D’Avolio, J Cusato, M Cantù, A De Nicolò Journal of pharmaceutical and biomedical analysis 166, 40-51, 2019 | 89 | 2019 |
HPLC–MS method for the simultaneous quantification of the antileukemia drugs imatinib, dasatinib and nilotinib in human peripheral blood mononuclear cell (PBMC) A D’Avolio, M Simiele, S De Francia, A Ariaudo, L Baietto, J Cusato, ... Journal of pharmaceutical and biomedical analysis 59, 109-116, 2012 | 88 | 2012 |
Development and validation of a UHPLC-MS/MS method for quantification of the prodrug remdesivir and its metabolite GS-441524: a tool for clinical pharmacokinetics of SARS-CoV-2 … V Avataneo, A de Nicolò, J Cusato, M Antonucci, A Manca, A Palermiti, ... Journal of Antimicrobial Chemotherapy 75 (7), 1772-1777, 2020 | 87 | 2020 |
A HPLC–MS method for the simultaneous quantification of fourteen antiretroviral agents in peripheral blood mononuclear cell of HIV infected patients optimized using medium … A D’Avolio, M Simiele, M Siccardi, L Baietto, M Sciandra, V Oddone, ... Journal of pharmaceutical and biomedical analysis 54 (4), 779-788, 2011 | 77 | 2011 |
Evaluation of the mean corpuscular volume of peripheral blood mononuclear cells of HIV patients by a coulter counter to determine intracellular drug concentrations M Simiele, A D'Avolio, L Baietto, M Siccardi, M Sciandra, S Agati, J Cusato, ... Antimicrobial agents and chemotherapy 55 (6), 2976-2978, 2011 | 75 | 2011 |
Cannabinoids concentration variability in cannabis olive oil galenic preparations C Carcieri, C Tomasello, M Simiele, A De Nicolò, V Avataneo, ... Journal of Pharmacy and Pharmacology 70 (1), 143-149, 2018 | 74 | 2018 |
The “scar” of a pandemic: Cumulative incidence of COVID‐19 during the first trimester of pregnancy S Cosma, F Borella, A Carosso, A Sciarrone, J Cusato, S Corcione, ... Journal of medical virology 93 (1), 537-540, 2021 | 72 | 2021 |
Inosine triphosphatase polymorphisms and ribavirin pharmacokinetics as determinants of ribavirin-associate anemia in patients receiving standard anti-HCV treatment A D'Avolio, A Ciancio, M Siccardi, A Smedile, L Baietto, M Simiele, ... Therapeutic drug monitoring 34 (2), 165-170, 2012 | 52 | 2012 |
UHPLC–MS/MS method with protein precipitation extraction for the simultaneous quantification of ten antihypertensive drugs in human plasma from resistant hypertensive patients A De Nicolò, V Avataneo, F Rabbia, G Bonifacio, J Cusato, C Tomasello, ... Journal of Pharmaceutical and Biomedical Analysis 129, 535-541, 2016 | 50 | 2016 |
Therapeutic drug monitoring of voriconazole for treatment and prophylaxis of invasive fungal infection in children S Allegra, G Fatiguso, S De Francia, F Favata, E Pirro, C Carcieri, ... British journal of clinical pharmacology 84 (1), 197-203, 2018 | 47 | 2018 |
Determinants of darunavir cerebrospinal fluid concentrations: impact of once-daily dosing and pharmacogenetics A Calcagno, A Yilmaz, J Cusato, M Simiele, R Bertucci, M Siccardi, ... AIDS 26 (12), 1529-1533, 2012 | 47 | 2012 |
Intracellular accumulation of atazanavir/ritonavir according to plasma concentrations and OATP1B1, ABCB1 and PXR genetic polymorphisms A D'Avolio, C Carcieri, J Cusato, M Simiele, A Calcagno, S Allegra, ... Journal of Antimicrobial Chemotherapy 69 (11), 3061-3066, 2014 | 46 | 2014 |
Kinetics and prediction of HB sAg loss during therapy with analogues in patients affected by chronic hepatitis B HB eAg negative and genotype D L Boglione, A D'Avolio, G Cariti, G Gregori, E Burdino, L Baietto, J Cusato, ... Liver International 33 (4), 580-585, 2013 | 46 | 2013 |
Development and validation of a new UPLC-PDA method to quantify linezolid in plasma and in dried plasma spots L Baietto, A D’Avolio, A Ariaudo, S Corcione, M Simiele, J Cusato, ... Journal of Chromatography B 936, 42-47, 2013 | 45 | 2013 |
Influence of CYP2B6 and ABCB1 SNPs on nevirapine plasma concentrations in Burundese HIV‐positive patients using dried sample spot devices A Calcagno, A D'Avolio, M Simiele, J Cusato, R Rostagno, V Libanore, ... British journal of clinical pharmacology 74 (1), 134-140, 2012 | 43 | 2012 |
Clinical pharmacology of tenofovir clearance: a pharmacokinetic/pharmacogenetic study on plasma and urines A Calcagno, J Cusato, L Marinaro, L Trentini, C Alcantarini, M Mussa, ... The pharmacogenomics journal 16 (6), 514-518, 2016 | 42 | 2016 |
Therapeutic drug monitoring‐guided definition of adherence profiles in resistant hypertension and identification of predictors of poor adherence V Avataneo, A De Nicolò, F Rabbia, E Perlo, J Burrello, E Berra, ... British journal of clinical pharmacology 84 (11), 2535-2543, 2018 | 41 | 2018 |
Genetic polymorphisms affecting the pharmacokinetics of antiretroviral drugs A Calcagno, J Cusato, A D’Avolio, S Bonora Clinical pharmacokinetics 56, 355-369, 2017 | 41 | 2017 |